Skip to main content
. 2019 Mar 28;4(6):864–872. doi: 10.1016/j.ekir.2019.03.016

Figure 2.

Figure 2

Kaplan−Meier cumulative event-free survival in MACE+ patients, by Dialysis Outcomes and Practice Patterns Study (DOPPS) phase in (a) North America, (b) Europe, and (c) Japan. MACE+, major adverse cardiovascular events (MACE) plus heart failure and thromboembolic events.